Loading...
Loading...
- Cellular Biomedicine Group Inc CBMG shares surged 51.9 percent to $8.05 after the company reported the addition of a second clinical site in expansion of chimeric antigen Phase 1 trial.
- Sorl Auto Parts, Inc. SORL shares climbed 33 percent to $6.04 after the company reported strong Q1 results and raised its guidance.
- Patheon NV PTHN shares climbed 33 percent to $34.58. Thermo Fisher Scientific Inc. TMO announced plans to acquire Patheon for $35 per share in cash.
- Cyren Ltd CYRN jumped 22.5 percent to $2.45. Cyren is expected to release quarterly earnings on May 16, 2017.
- Trivago NV – ADR TRVG climbed 20 percent to $21.41 after a mixed Q1 report that came inline on EPS, but about $6 million short on sales.
- Haynes International, Inc. HAYN shares surged 18.6 percent to $42.33. Longbow Research upgraded Haynes International from Neutral to Buy.
- Alnylam Pharmaceuticals, Inc. ALNY jumped 17.1 percent to $66.47. Alnylam Pharmaceuticals reported inducement grant to new Chief Financial Officer Manmeet S. Soni.
- Interpace Diagnostics Group Inc IDXG shares surged 15.5 percent to $2.76. Interpace Diagnostics posted Q1 earnings of $0.55 per share on revenue of $3.47 million.
- Ra Pharmaceuticals Inc RARX shares jumped 14.8 percent to $26.49.
- EnteroMedics Inc ETRM gained 13.6 percent to $5.28. EnteroMedics is expected to report Q1 results on Tuesday, May 16, 2017.
- Voxeljet AG (ADR) VJET rose 12.2 percent to $4.43. Cowen & Co. upgraded Voxeljet from Market Perform to Outperform.
- Euroseas Ltd. ESEA gained 11.5 percent to $1.26. On Friday, Euroseas posted a Q1 net loss of $2.2 million on revenue of $8.3 million.
- Wesco Aircraft Holdings Inc WAIR climbed 7.9 percent to $8.90. Jefferies upgraded Wesco Aircraft from Underperform to Hold.
- FireEye Inc FEYE shares surged 7.8 percent to $15.95 after gaining 2.35 percent on Friday.
- BiondVax Pharmaceuticals Ltd (ADR) BVXV shares climbed 7.3 percent to $7.83 after gaining 0.83 percent on Friday.
- Precision Drilling Corp (USA) PDS shares rose 7 percent to $3.93 after dropping 3.16 percent on Friday.
- Meritor Inc MTOR shares gained 4.1 percent to $17.17. RBC Capital initiated coverage on Meritor with an Outperform rating.
- Editas Medicine Inc EDIT gained 3.6 percent to $19.98. Editas Medicine demonstrated the first achievement of in vivo editing in non-human primate retinas at the American Society of Gene & Cell Therapy Annual meeting.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in